Excellent 3-year results following living-donor kidney transplantation and tacrolimus immunosuppression in Japan.
Uchida
K
K
Transplant Surgery 2-9 Myoken-Cho, Nagoya Daini Red Cross Hospital, Showa-ku, Nagoya 466-8650, Japan.
Takahashi
K
K
Takahara
S
S
Oshima
S
S
Toma
H
H
Sonoda
T
T
D005500:Follow-Up Studies; D006084:Graft Rejection / Q000453:epidemiology; D006085:Graft Survival / Q000502:physiology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007564:Japan; D016030:Kidney Transplantation / Q000276:immunology* / Q000401:mortality; D019520:Living Donors; D008875:Middle Aged; D011183:Postoperative Complications / Q000453:epidemiology; D015996:Survival Rate; D016559:Tacrolimus / Q000627:therapeutic use*; D013997:Time Factors; D016896:Treatment Outcome
D007166:Immunosuppressive Agents; D016559:Tacrolimus